HBM BioCapital I

HBM BioCapital (EUR) L.P. and HBM BioCapital (USD) L.P. are private equity funds with a total committed capital of EUR 115 million. The funds are focused on healthcare / life science investments in Europe and the U.S. and were launched in 2005.

HBM BioCapital I has made investments in 15 private companies in the pharma, biotechnology, medical devices and diagnostics industries, six of which have already been sold or listed on a stock exchange.

Larger transactions were shared with HBM BioVentures. Investors in HBM BioCapital I are HBM BioVentures, larger institutional investors and pharma entrepreneurs.

For further information, please contact Dr. Ulrich Geilinger, phone: +41 43 888 71 71 or by email ulrich.geilinger@hbmpartners.com.